Further complicating investigation of the mechanism underlying the pathogenesis of hypertension are racial differences in the effectiveness of the various classes of antihypertensives (Cushman et al., 2000; Johnson, 2008; Gupta, 2010), including the response to β-blockers, ACE inhibitors, and ARBs. This evidence concerns the gene ACE and Hypertension.